Targacept, Inc.
Srinivasa Murthy, Ph.D., is an accomplished Senior Scientist at Targacept, Inc. since 2006, with a solid background in the pharmaceutical industry. Prior to this role, Srinivasa held the position of Principal Scientist at ArQule Inc. from January 2000 to May 2006. With extensive experience in scientific research and development, Srinivasa has contributed significantly to advancements in the field.
This person is not in any teams
Targacept, Inc.
Targacept is developing a diverse pipeline of innovative NNR Therapeutics™ for difficult-to-treat diseases and disorders of the nervous system. NNR Therapeutics selectively modulate the activity of specific neuronal nicotinic receptors, unique proteins that regulate vital biological functions that are impaired in various disease states. Targacept’s clinical pipeline includes multiple Phase 2 product candidates, all representing first-in-class opportunities. Targacept leverages its scientific leadership and diverse pipeline to attract significant collaborations with global pharmaceutical companies. For more information, please visit www.targacept.com.